You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 3, March 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Pediatrics
 •Congenital Malformations
 •Neonatology and Infant Care
 •Diagnosis
 •Prognosis/ Outcomes
 •Dermatologic Disorders, Other
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Molecular Genetics as a Diagnostic and Prognostic Aid in the Assessment of Neonates With Red, Scaly Genodermatoses

Work Still in Progress

Suzanne E. Clements, MBChB, MRCP; John A. McGrath, MD, FRCP

Arch Dermatol. 2008;144(3):387-388.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A long differential diagnosis is a familiar scenario for many dermatologists caring for patients with inherited skin diseases, and no more so than when neonates present with dry, scaly, red, or eroded skin. An ability to make accurate diagnoses in such cases is often vitally important in patient management because the clinical course and prognosis of the conditions may vary widely—a real problem given the often overlapping and indistinguishable early physical signs.

For the perplexed clinician, some new diagnostic and prognostic help is at hand. Recent advances in understanding the molecular basis of more than 350 monogenic inherited diseases is now having a direct impact on patient care. The emerging translational benefits from genetics research are multiple: more accurate diagnoses, improved genotype-phenotype correlation, better genetic counseling, greater feasibility of DNA-based prenatal diagnosis, and new ideas about treatment, including gene, protein, . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.